Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

Sterility & contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections.

6,317 FDA drug recalls with this cause, newest first.

This is the single biggest cause in the register by a wide margin. It covers products that had to be sterile - injectables, eye drops, certain ointments - but could not be verified sterile, or were found contaminated during testing. Most of these recalls come from compounding pharmacies and outsourcing facilities after an FDA inspection finds gaps in how sterile products were made. Sterility failures are treated seriously because the products involved have the least room for error, going straight into the bloodstream or the eye.

Class I · High risk

BD ChloraPrep Hi-Lite Orange 2% w/v chlorhexidine gluconate

Non-sterility: Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

Terminated Sterility / contamination CareFusion 213, LLC NDC 54365-400-33 D-0268-2021
Class I · High risk

BD ChloraPrep Clear

Non-sterility: Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

Terminated Sterility / contamination CareFusion 213, LLC NDC 54365-400-32 D-0265-2021
Class II · Moderate risk

Sterile Curcumin 50mg/mL

Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

Terminated Sterility / contamination BIOTA Biosciences LLC D-1330-2020
Class II · Moderate risk

Sterile Cannabidiol

Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

Terminated Sterility / contamination BIOTA Biosciences LLC D-1329-2020
Class II · Moderate risk

Sterile Cannabidiol

Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

Terminated Sterility / contamination BIOTA Biosciences LLC D-1328-2020
Class II · Moderate risk

Sterile Curcumin

Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

Terminated Sterility / contamination BIOTA Biosciences LLC D-1327-2020
Class II · Moderate risk

Sterile Cannabidiol

Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

Terminated Sterility / contamination BIOTA Biosciences LLC D-1326-2020
Class II · Moderate risk

Methotrexate

Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.

Terminated Sterility / contamination Edge Pharma, LLC D-0226-2021